Search research articles
Contact Us
Filters
Showing results (31-40 of 93) with videos related to
Page
of 10
Sort By:
Leukemia & Lymphoma
|
August 22, 2012
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine
Peter L Greenberg, Guillermo Garcia-Manero, Michael Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials
Michael Zach Koontz, Sandra J Horning, Raymond Balise, et al.
Journal of Hematopathology
|
February 20, 2026
Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype
Jyoti Kumar, Alexandria Jensen, Rong Lu, et al.
Scientific Reports
|
November 23, 2013
Specific plasma autoantibody reactivity in myelodysplastic syndromes
George I Mias, Rui Chen, Yan Zhang, et al.
Leukemia Research
|
September 20, 2011
Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na
Mahesh Seetharam, Alice C Fan, Mai Tran, et al.
Blood Advances
|
June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms
Michael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Leukemia Research
|
December 28, 2023
The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms
Vishesh Khanna, Rong Lu, Jyoti Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2013
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Wendy W Pang, John V Pluvinage, Elizabeth A Price, et al.
Leukemia & Lymphoma
|
April 5, 2018
Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells
Hogune Im, Varsha Rao, Kunju Sridhar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2010
NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes
Peter L Greenberg, Cynthia K Rigsby, Richard M Stone, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 93) with videos related to
Sort By:
Page
of 10
Leukemia & Lymphoma
|
August 22, 2012
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine
Peter L Greenberg, Guillermo Garcia-Manero, Michael Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials
Michael Zach Koontz, Sandra J Horning, Raymond Balise, et al.
Journal of Hematopathology
|
February 20, 2026
Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype
Jyoti Kumar, Alexandria Jensen, Rong Lu, et al.
Scientific Reports
|
November 23, 2013
Specific plasma autoantibody reactivity in myelodysplastic syndromes
George I Mias, Rui Chen, Yan Zhang, et al.
Leukemia Research
|
September 20, 2011
Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.Na
Mahesh Seetharam, Alice C Fan, Mai Tran, et al.
Blood Advances
|
June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms
Michael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Leukemia Research
|
December 28, 2023
The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms
Vishesh Khanna, Rong Lu, Jyoti Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 8, 2013
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Wendy W Pang, John V Pluvinage, Elizabeth A Price, et al.
Leukemia & Lymphoma
|
April 5, 2018
Distinct transcriptomic and exomic abnormalities within myelodysplastic syndrome marrow cells
Hogune Im, Varsha Rao, Kunju Sridhar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2010
NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromes
Peter L Greenberg, Cynthia K Rigsby, Richard M Stone, et al.
Page
of 10